Deepbridge Capital



Andrew Aldridge: How the life science sector has shot up the investment agenda as vaccinations are rolled out

Andrew Aldridge, partner at Deepbridge Capital, discusses how investments in life sciences can be appealing to many investors as the COVID-19 vaccinations roll out globally. 

Published 18 March 2021